Close
Drug repurposing is the process of discovering new therapeutic uses for existing drugs.
Drug repurposing can encompass any one of the following activities:
- Repositioning drug candidates that are currently in clinical development to new disease indications
- Targeting drugs that have been abandoned or failed to demonstrate efficacy for a particular indication during phase II or III trials to new disease indications
- Targeting marketed or off-patent drugs to new disease indications
- Reformulation of drugs including novel delivery systems
- Novel combination therapies
The Repurposing Therapeutic Innovation Network aims to shape the pathway to accelerate the translational process for UCL repurposing projects. To achieve this we need to:
- Scope ongoing repurposing activities
- Establish core group
If you are involved/interested in repurposing and want to be part of shaping the Repurposing TIN please contact us.
